US SEC Filings Daily Market Digest — September 04, 2026

04-09-2026

Black Hawk Acquisition Corp filed an S-4/A registration statement with the SEC on September 3, 2026, in connection with its proposed business combination with Vesicor Therapeutics, a preclinical-stage biopharmaceutical company. The filing details shareholder voting procedures, redemption rights, and the company's ongoing efforts to regain compliance with Nasdaq's minimum market value of listed securities requirement. Black Hawk has experienced significant shareholder redemptions (69.2% of public shares) and is relying on sponsor loans to fund monthly extension payments, while Vesicor remains in early development with no approved products.

• · Black Hawk received a Nasdaq MVLS deficiency notice on March 31, 2026, with a compliance deadline of September 28, 2026.
• · The company has issued five convertible notes to its sponsor since June 2025, totaling $1.6 million in principal, to fund monthly extension payments.
• · Vesicor is a preclinical-stage biopharmaceutical company with no approved products and limited business activities beyond R&D.
• · Shareholders who fail to vote but do not redeem will become stockholders of PubCo if the business combination is approved.

04-09-2026

SoundHound AI, Inc. filed an S-4MEF registration statement on September 4, 2026, to register 726,888 shares of Class A common stock for issuance in connection with its acquisition of LivePerson, Inc. The filing incorporates by reference the prior S-4 registration statement (No. 333-296284) and includes consents from LivePerson's independent auditor (BDO USA, P.C.) and financial advisor (Houlihan Lokey Capital, Inc.). The registration fee for this additional offering is $277.06, based on a maximum aggregate offering price of $2,006,210.88.

• · The S-4MEF filing is an automatic shelf registration statement for additional securities of the same class as previously registered.
• · The merger agreement is dated July 2, 2026 (Amended and Restated Agreement and Plan of Merger).
• · The prior S-4 registration statement was initially filed on May 27, 2026, amended on July 2 and July 8, 2026, and declared effective on July 9, 2026.
• · LivePerson's stock price used for calculation was $2.76 (average of high and low on August 28, 2026).
• · LivePerson common stock has a par value of $0.001 per share; SoundHound Class A common stock has a par value of $0.0001 per share.

04-09-2026

Charging Robotics Inc. (CHEV) announced that its wholly owned Israeli subsidiary, Charging Robotics Ltd., will sell a 51% controlling stake to Clearmind Medicine Inc. for $2.5 million, while the parent retains a 49% interest. Concurrently, Clearmind will provide a $1.5 million loan to the subsidiary at 4% interest, maturing in three years. The transactions are expected to close in the week of September 7, 2026, and will result in Charging Robotics Ltd. being deconsolidated from the parent's financial statements.

• · The loan matures on the third anniversary of the effective date, with automatic extension until Charging Robotics Ltd. generates positive cash flow from operating and financing activities sufficient to repay.
• · Charging Robotics Ltd. may prepay the loan at any time without penalty.
• · Clearmind can accelerate the loan upon events of default, including failure to make payment within 15 business days, insolvency proceedings, or enforcement against a material portion of assets.
• · The transaction will result in deconsolidation of Charging Robotics Ltd. from Charging Robotics Inc.'s financial statements.
• · The filing includes unaudited pro forma condensed consolidated financial information as Exhibit 99.1.

04-09-2026

Private Bancorp of America, Inc. (PBAM) reported strong financial results for Q2 2026, with net income rising 25.5% YoY to $13.1M and diluted EPS increasing to $2.27 from $1.77. Net interest income grew 11.4% to $33.5M, driven by higher loan and investment income, while interest expense declined 17.2% due to lower deposit costs. However, noninterest income fell sharply by 42.1% to $1.0M, primarily due to a significant drop in SBA loan sale gains, and total noninterest expenses rose 7.5% to $16.9M. Total assets increased 6.8% to $2.71B, supported by strong deposit growth of $157M during the first half of the year.

• · Provision for credit losses reversed to a benefit of $204K in Q2 2026, compared to a provision of $1.3M in Q2 2025.
• · Gain on sale of SBA loans dropped sharply to $4K in Q2 2026 from $523K in Q2 2025.
• · Other real estate owned (OREO) increased to $13.6M as of June 30, 2026, from $8.6M at year-end 2025.
• · Net cash provided by operating activities more than doubled to $26.5M in H1 2026 from $12.9M in H1 2025.
• · The company repurchased $3.0M of common stock during H1 2026, with no such repurchases in H1 2025.
• · Accumulated other comprehensive loss worsened to $(6.2M) from $(4.9M) at year-end 2025, driven by unrealized losses on securities.

04-09-2026

Movano Inc. (now Corvex, Inc.) filed an S-3 shelf registration statement on September 4, 2026, to register the offer and sale of unspecified securities, with proceeds intended for working capital and general corporate purposes. The filing reflects a 1.358-for-1 stock dividend (accounted for as a stock split) declared in connection with a Merger Agreement, which increased weighted average shares outstanding. The company's net loss narrowed to $18.3 million in 2025 from $23.7 million in 2024, though it remains loss-making.

• · Stock dividend of 0.358 shares per share declared, accounted for as a 1.358-for-1 stock split, distributed on approximately April 6, 2026.
• · Stock dividend did not change par value or authorized shares; proportionate adjustments made to equity plans and warrants.
• · Series B, C, and D Preferred Stock and assumed Corvex OpCo equity awards were not eligible for the stock dividend.
• · Net loss per share (as adjusted) improved from $(29.01) in 2024 to $(16.02) in 2025.
• · Proceeds from securities sales will be used for working capital and general corporate purposes, including infrastructure deployment and commercialization activities.

04-09-2026

NutriBand Inc. reported a net loss of $880,561 for Q2 FY26 (three months ended July 31, 2026), a significant improvement from a net loss of $2,000,337 in the same quarter last year. Revenue declined 29.7% YoY to $437,514, while total costs and expenses were cut by 49.4% to $1,328,151. However, the company continues to burn cash, with cash and cash equivalents falling 25.2% from $4,574,857 at January 31, 2026 to $3,421,615.

• · Revenue is entirely from the United States; no foreign revenue reported.
• · Revenue is solely from sale of goods; no service revenue in FY26.
• · Research and development expenses fell 42.7% YoY in Q2 to $322,194 and 54.3% in H1 to $569,455.
• · Selling, general and administrative expenses declined 53.0% YoY in Q2 to $750,317 and 24.2% in H1 to $1,954,208.
• · Stock-based compensation (shares, options, warrants) was $772,828 in H1 FY26 vs $104,400 in H1 FY25, a 640% increase.
• · Net cash used in operating activities improved to $1,148,103 in H1 FY26 from $2,650,313 in H1 FY25.
• · No cash was raised from equity or warrant exercises in H1 FY26, compared to $5,305,503 in H1 FY25.
• · Accumulated deficit grew to $48,814,785 as of July 31, 2026 from $46,692,268 at January 31, 2026.
• · No preferred stock dividend was declared in FY26, compared to $21,814,166 in H1 FY25.

04-09-2026

Wetour Robotics (NASDAQ: WETO) released a development demonstration of its Orchestra system, combining surface electromyography (sEMG) with first-person vision to capture richer human-hand data for robot learning. The system aims to address limitations of vision-only capture, such as inability to measure force and data loss during visual occlusion. However, the force-estimation pipeline has only been validated on synthetic data, and the cross-modal correction strategy remains in validation, indicating early-stage development.

• · The system is designed to fuse sEMG and vision streams locally into one synchronized record of movement, effort, and action timing.
• · The force-estimation pipeline converts sEMG into scale-calibrated, kilogram-equivalent grasp-force estimates, but validation with live wristband force recordings remains under development.
• · The demonstration includes five real-world tasks: packing a lunch box, sorting pills, disassembling a pen, measuring a drone with calipers, and installing a drone propeller.
• · The system layers events such as reach, grasp, hold, and release over continuous hand motion for imitation learning and robot training.

04-09-2026

ClearOne Inc. filed an amended S-1 registration statement for a best-efforts offering of Units at $3.50 per Unit, with proceeds ranging from $10 million (minimum) to $15 million (maximum). The company is pursuing a merger with Vivani (issuing 12.5 million Consideration Shares) and concurrently registering 2,496,162 shares held by selling stockholders, which represent 93.30% of pre-offering shares. However, the company has only $0.7 million in cash, its auditor has expressed substantial doubt about its ability to continue as a going concern, and investors will face immediate dilution of $3.13 to $2.93 per share.

• · The offering is a best-efforts arrangement; the Placement Agent has no obligation to buy any securities.
• · There is no public market for the Warrants offered, and the company does not intend to list them on any exchange.
• · The company's continuing activities are not expected to generate material revenue sufficient to fund ongoing operating costs.
• · The company may need to raise additional funds, which may not be available on acceptable terms.
• · The company faces intense competition for qualified personnel in the medical technology and neurostimulation industries.
• · The company expects to incur significant costs related to Sarbanes-Oxley compliance, and testing may reveal material weaknesses in internal controls.

04-09-2026

ChargePoint Holdings reported Q2 FY2026 (three months ended July 31, 2026) revenue of $116.1M, up 17.7% YoY from $98.6M, with gross profit improving to $42.3M from $30.7M. Net loss narrowed to $35.6M from $66.2M YoY, and operating expenses fell 14.9% YoY. However, the company's cash position declined sharply to $95.7M from $142.0M at the start of the fiscal year, and total stockholders' equity turned negative at -$36.1M, reflecting continued cash burn and accumulated losses.

• · Q2 FY2026 revenue by segment: Networked Charging Systems $62.9M (up 24.8% YoY), Subscriptions $43.7M (up 9.5% YoY), Other $9.5M (up 14.3% YoY).
• · Q2 FY2026 gross margin improved to 36.4% from 31.2% in Q2 FY2025.
• · Q2 FY2026 R&D expenses declined 11.2% YoY to $32.4M; sales and marketing declined 6.3% YoY to $23.5M; G&A declined 27.3% YoY to $20.5M.
• · Six-month FY2026 net loss narrowed to $78.8M from $123.3M in the prior year period.
• · Net cash used in operating activities for H1 FY2026 was $40.8M, slightly higher than $39.1M in H1 FY2025.
• · Inventories decreased to $179.5M from $214.9M at fiscal year start, a 16.5% reduction.
• · Debt, current and noncurrent, totaled $236.9M as of July 31, 2026, down from $260.9M at January 31, 2026.
• · Accumulated deficit widened to $2.19B as of July 31, 2026.
• · The company issued 1,604,776 shares of common stock in connection with contractual Interest Shares during H1 FY2026, valued at $9.4M.
• · A reverse stock split occurred in the prior year (fractional share adjustment of 2,821 shares in Q2 FY2025).

04-09-2026

3i, LP and related parties (3i Management LLC, Maier J. Tarlow) filed an amended Schedule 13G, reverting from a Schedule 13D, after their investment intent changed away from influencing control of Valion Bio, Inc. (formerly Tivic Health Systems, Inc.). The group beneficially owns 132,671 shares of common stock (9.9% of 1,285,626 shares outstanding as of August 24, 2026), consisting of 90,252 shares directly held and 42,419 shares issuable upon exercise of warrants and conversion of a $16,253,147.10 senior secured convertible note and preferred stock, all subject to a 9.99% blocker. The filing reflects a passive investment stance.

• · The filing is an amendment to a Schedule 13D, reverting to a Schedule 13G under Rule 13d-1(c) and 13d-1(h) because the reporting persons no longer hold securities with the purpose of changing or influencing control.
• · The company underwent a 1-for-25 reverse stock split effective August 31, 2026, and all share amounts reflect that split.
• · Tumim Stone Capital, LLC holds zero shares of the issuer.
• · The beneficial ownership percentage is based on 1,285,626 shares outstanding as of August 24, 2026, as verified with the issuer.

04-09-2026

Flex (NASDAQ: FLEX) announced a definitive agreement to acquire EPC Power for $4.4 billion, adding leading power conversion capabilities for AI data centers and grid applications. EPC Power is expected to generate approximately $800 million of revenue in calendar 2026 with organic revenue growth of ~40% expected in 2027, and EBITDA margin expected to expand to ~30% in 2027. Flex also plans to separate its Cloud and Power Infrastructure (CPI) segment into an independent publicly traded company in the first calendar quarter of 2027.

• · EPC Power was founded in 2010 and is headquartered in California.
• · EPC Power has more than 15 GW deployed across 62 countries.
• · Annual U.S. manufacturing capacity will surpass 30 GW in 2027.
• · The transaction is expected to close in Q4 of calendar 2026.
• · Flex plans to separate CPI into an independent publicly traded company in Q1 2027.
• · Committed financing is being provided by Citi and Bank of America.
• · Evercore acted as lead financial advisor to Flex; Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC served as financial advisors to EPC Power.

04-09-2026

AIxCrypto Holdings, Inc. (AIXC) filed an S-1/A registration statement for its IPO, highlighting its pivot to RoboShare, an on-demand robot-sharing marketplace that launched in June 2026. The company has completed only two paid orders totaling approximately $5,000 in August 2026, with an additional $33,000 one-year rental order pending payment and enforceability. While 82 robots are listed on the platform, the company has no operating history, no revenue recognition yet, and has wound down its legacy biotech and crypto initiatives, presenting a high-risk, pre-revenue profile for investors.

• · RoboShare launched publicly on June 22, 2026, with first paid order milestone on August 15, 2026.
• · Los Angeles is the primary operating market; a ten-city direction is planned but not committed.
• · The company does not own any robot equipment; all robots are third-party-owned.
• · Customer-acquisition channels include events, direct outreach, LinkedIn, and referrals; inquiry-to-fulfillment is largely manual.
• · The company has wound down BesTrade, C10, and legacy biotechnology operations (including QN-302).
• · RWA tokenization, EAI infrastructure, and AIxC Hub are deprioritized and not near-term focuses.
• · The company has offices in El Segundo, California; storage and staging arrangements are being developed.
• · Automated scheduling, merchant portal, and payment splitting remain under development.
• · The operating entity is AIXCRYPTO EAI, INC., a Delaware corporation.
• · The company does not offer venue or space rental services.

04-09-2026

TD Bank Group announced senior leadership appointments on September 3, 2026, in a move to further accelerate its strategy. The filing does not contain any financial metrics or performance data, so no quantitative analysis is possible. A routine leadership change announcement with no financial details.

04-09-2026

NetEase, Inc. filed a Form 6-K with the SEC on September 4, 2026, attaching a monthly return submitted to the Hong Kong Stock Exchange regarding movements in its securities. This is a routine regulatory filing that does not disclose any material financial or operational changes.

04-09-2026

Director Elze Christian was awarded 17,000 Stock Options (Right to Buy).

• · Director Elze Christian was awarded 17,000 Stock Options (Right to Buy)
• · Director Elze Christian was awarded 8,500 Restricted Stock Units

04-09-2026

Enigmatig Ltd (EGG) filed an F-3 shelf registration statement with the SEC on September 4, 2026, to register an unspecified amount of securities for future offerings. The company is a Cayman Islands exempted company with a dual-class share structure (Class A: 1 vote per share; Class B: 10 votes per share) and authorized share capital of US$50,000 divided into 25 billion shares. The filing does not disclose any specific offering terms, use of proceeds, or financial results, and incorporates by reference its most recent Annual Report on Form 20-F and subsequent Form 6-K filings.

• · The company was incorporated in the Cayman Islands on May 30, 2023.
• · No equity incentive plan or share-based compensation arrangement has been adopted.
• · Class B ordinary shares carry 10 votes per share and are convertible into Class A ordinary shares at the holder's option; Class A shares cannot be converted into Class B.
• · The company relies on home country practice to exempt itself from NYSE American corporate governance requirements, including the independence of a majority of directors.
• · Shareholders holding at least one-third of voting rights can requisition an extraordinary general meeting.
• · The company is not obliged to hold annual general meetings under Cayman Islands law.
• · Dividends may be paid out of profit or share premium account, subject to solvency conditions.
• · Variation of class rights requires consent of holders of at least two-thirds of the issued shares of that class.

04-09-2026

Ionis Pharmaceuticals announced on September 3, 2026, that the FDA approved ZANVASTRO (zilganersen) for Alexander disease (AxD) in pediatric and adult patients, making it the first disease-modifying treatment for this ultra-rare disorder. The approval was based on a Phase 3 study that met its primary endpoint (gait speed stabilization, p=0.041) and showed a favorable safety profile; however, the approval also carried a Priority Review Voucher, and U.S. availability is weeks away, while regulatory submissions in Europe and Japan are expected in 2027. The company recorded a 9.3% year-over-year revenue decline in Q3 2025, with full‑year 2025 revenue down 12% and Q4 2025 revenue flat, reflecting ongoing transition to commercial-stage products.

• · ZANVASTRO 50 mg is administered quarterly as an intrathecal injection.
• · AxD affects approximately 1 in 1 to 3 million people worldwide.
• · The Phase 3 trial achieved statistically significant stabilization of gait speed (10-Meter Walk Test) at Week 61 (p=0.041).
• · Serious treatment-emergent adverse events occurred less frequently in the ZANVASTRO group than in control.
• · Ionis has licensed ex-U.S. rights to Recordati (Italy); regulatory submissions in Europe and Japan expected in 2027.
• · Product revenue from SPINRAZA royalties was flat in Q4 2025 at $97 million.
• · Full-year 2025 revenue declined 12% to $730 million, reflecting loss of U.S. SPINRAZA royalties after the patent settlement.

04-09-2026

Rent the Runway, Inc. has entered into a Stipulation and Agreement of Settlement to resolve a putative class action lawsuit related to its IPO, agreeing to pay a total settlement consideration of $9,000,000. The settlement consists of $6,000,000 in cash (with $3,100,000 from the company and $2,900,000 from insurers) and $3,000,000 in Class A common stock (or cash at the company's discretion). The settlement is subject to court approval and involves no admission of liability, but represents a material financial obligation for the company.

• · Lawsuit filed on November 14, 2022 in Eastern District of New York (Case No. 22-cv-6935)
• · Allegations under Sections 11 and 15 of the Securities Act of 1933 regarding misleading statements and omissions about company growth at IPO
• · Settlement is without admission of liability, wrongdoing, damages, negligence, or fault
• · Settlement requires both preliminary and final approval by the District Court
• · Company may, in its sole discretion, pay all or a portion of the $3,000,000 stock component in cash instead

04-09-2026

NatWest Group plc disclosed that three PDMRs (including the CEO, CFO, and Retail CEO) sold a total of 391,000 shares on 2 September 2026 at £6.9023 per share. The transactions represent routine insider sales and do not indicate any change in corporate strategy or financial outlook.

• · All three PDMRs sold shares at the same price of £6.9023 per share on the same date (2 September 2026).
• · Paul Thwaite (CEO) sold the most shares: 260,000.
• · Katie Murray (CFO) sold 111,000 shares.
• · Solange Chamberlain (Retail CEO) sold 20,000 shares.

04-09-2026

Senti Biosciences Holdings, Inc. completed the issuance of $2.0 million in Senior Secured Convertible Notes to NSG BioInnovation Fund and entered into an equity commitment letter with an affiliate of Celadon Partners for $2.5 million in common stock, both on September 3, 2026. These financings are tied to a potential merger with a Celadon affiliate, which may also involve a contingent value right of up to $60.0 million based on SENTI-202 milestones. The company has filed a preliminary proxy statement for stockholder approval of these transactions, but no financial results or operational metrics are disclosed in this filing.

• · The Notes were issued under a Securities Purchase Agreement dated April 27, 2026, as amended on September 1, 2026.
• · The equity commitment letter with Celadon affiliate includes a purchase price equal to the 'Minimum Price' under Nasdaq Listing Rule 5635(d).
• · The contingent value right could pay up to $60.0 million in cash upon achievement of regulatory and sales milestones for SENTI-202.
• · A preliminary proxy statement on Schedule 14A was filed with the SEC on July 21, 2026, regarding the Subject Transactions.
• · The company is an emerging growth company and has elected not to use the extended transition period for new accounting standards.

04-09-2026

Noah Holdings Limited filed a Form 6-K with the SEC for September 2026, attaching a monthly return on movements in securities for equity issuers and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules. The filing is a routine regulatory disclosure and does not contain any financial results, material events, or operational updates.

04-09-2026

United Microelectronics Corporation (UMC) filed a Form 6-K with the SEC on September 4, 2026, as a routine foreign issuer report. The filing was signed by CFO Chitung Liu and contains no financial results, material events, or operational updates beyond the standard regulatory submission.

04-09-2026

The Trade Desk announced a workforce reduction of approximately 15% as part of an organizational realignment to focus on high-priority growth opportunities and improve operational efficiency. The company expects to incur cash restructuring charges of $39 million to $51 million in Q3 2026, partially offset by a reversal of $4 million to $5 million in stock-based compensation. While the restructuring aims to position the company for long-term growth, it involves significant near-term costs and workforce reductions.

• · The workforce reduction will be substantially completed during Q3 2026.
• · The company may incur additional charges or cash expenditures not currently contemplated due to unanticipated events.
• · The company will file an amended 8-K if amounts differ materially from estimates.

04-09-2026

RE/MAX Holdings, Inc. filed Form 15 with the SEC on September 4, 2026, to terminate its registration and suspend its duty to file reports under Section 12(g) of the Securities Exchange Act of 1934. This action follows the completion of a merger on August 24, 2026, whereby the company was acquired by Real REMAX Group Inc. and its shareholders received cash for their shares, resulting in zero holders of record of Class A Common Stock.

• · The merger agreement was entered into on April 26, 2026 and amended on June 12, 2026.
• · The first merger (Merger Sub I into the Company) and subsequent merger (Company into Merger Sub II) both occurred on August 24, 2026.
• · The resulting entity, Wildlife Acquisition II LLC, is a wholly owned subsidiary of Real REMAX Group Inc.
• · The principal executive offices of the registrant are located at c/o Real REMAX Group Inc., 701 Brickell Avenue, 17th Floor, Miami, Florida 33131.
• · The Form 15 certification was signed by Leah Jenkins, Chief Accounting Officer.

04-09-2026

SK hynix Inc. issued a Form 6-K to clarify a media report that its U.S. subsidiary Solidigm is pursuing a pre-IPO capital raising of approximately KRW 5 trillion. The company states that while Solidigm is reviewing various measures to strengthen competitiveness, no definitive matters have been determined as of the filing date. SK hynix will provide further disclosure either when specific details are confirmed or within three months.

• · The clarification follows a similar disclosure on August 6, 2026.
• · No definitive decision has been made regarding Solidigm's capital raising as of September 4, 2026.
• · The company commits to further disclosure within three months if no specific details are confirmed earlier.

04-09-2026

H World Group Limited announced a proposed offering of CNY-denominated bonds on September 4, 2026. The filing is a Form 6-K submitted to the SEC, with the bond offering details to be provided in Exhibit 99.1. No financial figures or performance metrics were disclosed in this preliminary announcement.

• · The bond offering is denominated in Chinese Yuan (CNY).
• · The filing was made for the month of September 2026.
• · The registrant's principal executive office is located at No. 1299 Fenghua Road, Jiading District, Shanghai, People's Republic of China.

04-09-2026

PBT Land & Minerals, Inc. filed an S-1/A registration statement for a rights offering and business combination. The company expects to raise $120.0 million in gross proceeds from the rights offering and private placements, with a backstop commitment of up to $71.2 million from SoftVest and Horizon Kinetics. The offering is contingent on shareholder approval of the business combination and the closing of the Blackbeard contribution.

• · The Subscription Rights are non-transferable and expire 25 days from issuance.
• · Unitholders receive one Subscription Right per Trust Unit owned as of the Record Date.
• · The Subscription Price per share is not yet disclosed (placeholder $).
• · The Rights Offering includes a Basic Subscription Right and an Over-Subscription Right.
• · No fractional shares will be issued; fractional shares will be rounded to the nearest whole share.
• · The Backstop Purchasers will not receive a fee for providing the Backstop Commitment.
• · The company expects Class A Shares to trade on NYSE and NYSE Texas under symbol 'PBT'.
• · The Board is making no recommendation regarding exercise of Subscription Rights.

04-09-2026

Legion Capital Acquisition Corp. filed an S-1 registration statement with the SEC on September 4, 2026, for an initial public offering. The SPAC, which changed its name from Legion Acquisition Corp. on August 24, 2026, is incorporated in the Cayman Islands (E9) and headquartered in Greenwich, Connecticut. The filing details the proposed offering of units, the over-allotment option, and various redemption and dilution scenarios, but does not disclose the specific number of units or the offering price.

• · The company changed its name from Legion Acquisition Corp. to Legion Capital Acquisition Corp. on August 24, 2026.
• · The company is a Cayman Islands exempted company (E9) with a fiscal year end of December 31.
• · The SEC file number is 333-298754 and the film number is 261360032.
• · The filing includes detailed scenarios for redemptions at 100%, 75%, 50%, 25%, and 0% of maximum, with and without the full over-allotment option.
• · The filing references private units, deferred underwriting commissions, and offering costs excluded from tangible book value.
• · The company is a non-accelerated filer and a limited liability company.

04-09-2026

Dorian LPG Ltd. announced three new VLGC newbuild contracts with Hanwha Ocean for ~$345M, a new $368.4M credit facility to refinance existing debt, and provided forward chartering estimates for the quarter ending September 30, 2026. The company has fixed 99% of its calendar days at a rate exceeding $88,000 per day, reflecting strong market conditions. However, the filing also notes forward-looking risks and does not disclose prior-period comparisons for charter rates or fleet utilization, limiting the ability to assess performance trends.

• · New VLGCs will be dual-fuel (LPG and low-sulphur fuels) with Shaft Generator system
• · Vessel hull and engine optimized for larger propellers and energy-saving devices
• · Vessels designed to transit 'the old' Panama Canal locks
• · New credit facility consolidates four existing facilities (2023 A&R Facility, Cougar and Cresques Japanese Financings, Commander tranche of BALCAP Facility)
• · Facility syndicate includes multiple international banks; Crédit Agricole acts as Sustainability Coordinator
• · No prior-period charter rate or fleet utilization data provided for comparison

04-09-2026

Profound Medical Corp. announced that its management will participate in the Lake Street Capital Markets 'BIG10' Conference on September 10, 2026 in New York City. The disclosure is a routine Regulation FD announcement and does not include any financial results, material business developments, or forward-looking guidance.

• · Conference date: September 10, 2026
• · Location: New York City
• · Filing date: September 3, 2026

04-09-2026

Micware Co., Ltd. filed a Form 6-K on September 3, 2026, announcing new growth strategies for its two platform businesses via a press release and an accompanying investor presentation. The filing is a routine disclosure of strategic plans and does not contain any financial results or performance metrics.

• · The press release was issued on September 3, 2026.
• · The presentation will be published on the company's investor relations website and used with potential investors.
• · The filing is under Commission File Number 001-43279.
• · The company's principal executive office is in Kobe, Hyogo, Japan.

04-09-2026

News Corporation filed an 8-K on September 4, 2026, to disclose its daily stock repurchase transactions under the existing $1 billion buyback program, as required by the Australian Securities Exchange (ASX). The filing includes forward-looking statements about the company's intent to repurchase shares, subject to market conditions and other factors. No financial results or material changes were reported.

• · The repurchase program covers both Class A common stock (NWSA) and Class B common stock (NWS).
• · Disclosures to the ASX are provided daily for any transactions under the program.
• · The filing includes forward-looking statements subject to risks such as market price changes, general market conditions, and securities laws.

04-09-2026

Immuron Ltd announced an exclusive distribution agreement with Calmino group AB to launch PROIBS® in the U.S. digestive/gut health supplement market, valued at $4.16 billion. The product is a medical device for abdominal pain and bowel issues, backed by a usability study where 94% of 1,003 users found it helpful. However, the filing provides no financial terms of the agreement or revenue projections, and PROIBS® was only recently launched in Australia during FY26, so U.S. commercial traction remains unproven.

• · PROIBS contains AVH200 derived from Aloe barbadensis Mill, with gel-forming components supporting the intestinal mucosal barrier.
• · PROIBS has been on the Swedish pharmacy market for more than a decade.
• · The product is classified as a medical device and is European certified.
• · Immuron's commercial growth strategy includes bringing a portfolio of innovative digestive health products to market, following rapid growth of Travelan sales in the US.

04-09-2026

Body and Mind Inc. announced it received $2.5 million in contingent proceeds from a previously disclosed Ohio equity interest transaction. The funds will be used for debt repayment, ongoing litigation in Arkansas, and general corporate purposes. No prior-period comparison data or performance metrics were provided in this filing.

• · The contingent proceeds were outlined in an Ohio equity interest transaction originally disclosed in a news release dated July 24, 2023.
• · Proceeds will be applied to debt repayment, ongoing litigation in Arkansas, and general corporate purposes.

04-09-2026

Repligen Corporation is acquiring BioLife Solutions, Inc. via a merger. BioLife stockholders will receive a mix of cash and Repligen common stock, with the merger expected to close in Q4 2026. BioLife shareholders are estimated to own approximately 11.1% of the combined company. The merger is subject to shareholder approval, antitrust clearance, and other customary conditions.

• · Merger expected to close in Q4 2026.
• · Conditions include shareholder approval, HSR Act waiting period expiration, no legal prohibition, SEC registration effectiveness, and Nasdaq listing authorization.
• · BioLife stockholders who do not vote in favor and meet other requirements may seek appraisal rights under Delaware law.
• · The merger is intended to qualify as a tax-free reorganization for U.S. holders (gain only to extent of cash received).
• · BioLife Solutions focuses on biopreservation media and cell processing products for cell and gene therapy.
• · Repligen develops bioprocessing technologies for biological drug manufacturing.

04-09-2026

Goldgroup Mining Inc. filed a Form 6-K with interim financial statements and MD&A dated August 31, 2026, along with a business acquisition report dated August 25, 2026. The filing also includes technical reports and consents for the DDGM and Back Forty projects, indicating ongoing development activities. No specific financial figures were disclosed in the filing, so performance trends cannot be assessed.

• · The filing includes a business acquisition report dated August 25, 2026, indicating a recent acquisition.
• · Technical reports (NI 43-101) for DDGM and Back Forty projects are included, dated March 30, 2026 and November 15, 2023 respectively.
• · The interim financial statements and MD&A are dated August 31, 2026.

04-09-2026

Nixxy, Inc. received a Nasdaq deficiency notice on September 1, 2026, for failing to maintain a minimum bid price of $1.00 per share for 30 consecutive business days, triggering a 180-day grace period to regain compliance. Concurrently, the company announced the resignation of director Ashissh Raichura and the appointment of Joe Conlon as a new director and Audit Committee Chairman, while Elsa Sung was appointed CFO with an annual base salary of $169,800 and equity awards. The delisting risk and leadership changes create significant uncertainty, though the company intends to monitor its bid price and explore options to cure the deficiency.

• · Nasdaq notice does not result in immediate delisting; company has 180-day grace period ending around February 28, 2027.
• · If not compliant by then, company may qualify for a second 180-day period if it meets other listing standards and intends to effect a reverse stock split.
• · Ashissh Raichura's resignation was not due to any disagreement with the company.
• · Elsa Sung has over 20 years of financial experience, is a licensed CPA (inactive), and previously served as CFO of a Nasdaq-listed company.
• · Joe Conlon received 50,000 shares upfront and 50,000 shares annually vesting quarterly, plus $3,000 monthly.
• · CFO employment agreement includes one month severance if terminated without cause after 90 days, and four months severance upon change of control termination.

04-09-2026

ACRES Commercial Realty Corp. entered into two new at-the-market (ATM) equity distribution agreements on September 3, 2026: one with Raymond James & Associates for up to $50 million of common stock, and another with Seaport Global Securities LLC for up to 2,980,000 shares of Series C Preferred Stock and up to 2,192,143 shares of Series D Preferred Stock. The company also terminated its prior preferred equity distribution agreement with Jones Trading Institutional Services LLC, effective September 1, 2026, under which only 7,857 shares of Series D Preferred Stock had been sold out of a possible 2,200,000 shares. Both new agreements provide the company with additional capital-raising flexibility, but the prior program's very low utilization suggests limited near-term demand for preferred equity.

• · The new Common ATM program replaces no prior agreement; it is a new facility for common stock.
• · The new Preferred Distribution Agreement replaces the prior agreement with Jones Trading dated October 4, 2021.
• · The prior preferred program had very low utilization: only 7,857 Series D shares sold out of 2,200,000 authorized (0.36%).
• · Both new agreements carry a maximum 2.0% commission to the sales agent.
• · Shares under both programs will be issued under the existing S-3 shelf registration (No. 333-278433) effective April 1, 2024.

04-09-2026

RCI Hospitality Holdings, Inc. entered into a one-year employment agreement with Interim President and CEO Travis Reese, effective September 1, 2026. The agreement provides an annual salary of $650,000, bonus eligibility, benefits, and perquisites including company car and aircraft access. This formalizes Mr. Reese's leadership role but does not include any financial results or operational updates.

• · Employment agreement is for a one-year term effective September 1, 2026.
• · Mr. Reese is bound by a confidentiality provision and a non-compete clause post-termination.
• · The agreement includes two weeks' paid vacation annually.
• · The filing was signed by Travis Reese on September 2, 2026.

04-09-2026

Embraer announced an additional order from ANA Holdings Inc. for eight E190-E2 aircraft, increasing ANA HD's total firm orders for the E2 family to 23 aircraft, with five additional options still held. The deal builds on a 2025 order for 15 E190-E2 firm aircraft and underscores ANA HD's confidence in Embraer's technology for reduced environmental impact and operating costs. No negative or flat metrics are present in this filing.

• · ANA HD's first E2 aircraft is scheduled for delivery in 2028.
• · Embraer E-Jets have been operating in Japan since 2009.
• · ANA HD has been recognized by Fortune as one of the World's Most Admired Companies and included in the Dow Jones Best-in-Class indices for multiple consecutive years.

04-09-2026

ECOMINAS CORP. filed Amendment No. 10 to its S-1 registration statement on September 3, 2026, for an initial public offering of 40,000,000 common shares. The company's common stock is quoted on the OTCQB Venture Market with limited trading activity, and it has 48,215,467 shares outstanding prior to the offering. The company has never paid dividends and does not expect to in the foreseeable future.

• · The Series B Preferred Stock is not convertible into common stock, providing Mr. Canelon continuing voting control.
• · The offering covers 40,000,000 shares, with up to 611,784,658 authorized but unissued common shares remaining.
• · The company has not adopted any formal equity compensation plan.
• · ECOMINAS has a beneficial-ownership limitation of 4.9% for Series A Preferred Stock; conversion terms include possible bonus shares.
• · The registrant qualifies as a non-accelerated filer; at least one year has passed since it ceased being a shell company.

04-09-2026

New Pacific Metals Corp. filed its Form 6-K with the SEC for September 2026, submitting its annual financial statements and management's discussion and analysis (MD&A) for the fiscal year ended June 30, 2026. The filing also includes certifications from the CEO and CFO, as well as consents from various experts. No specific financial figures or performance metrics are disclosed in this cover filing.

• · Filing includes annual financial statements and MD&A for the year ended June 30, 2026.
• · Certifications by CEO and CFO under Form 52-109F2 are included.
• · Consents from Deloitte and seven other experts (A Candido, A Zhang, J Ji, J Millard, K Murray, M Schulte, S Elfen) are provided.

04-09-2026

COO Ye Gang sold 10,832 Class A ordinary shares at $112.67 (~$1.22M). 5 transactions reported in total. Ye Gang holds 218,792 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

• · COO Ye Gang sold 9,168 Class A ordinary shares at $112.23 (~$1.03M)
• · COO Ye Gang sold 10,832 Class A ordinary shares at $112.67 (~$1.22M)
• · COO Ye Gang sold 2,300 Class A ordinary shares at $112.14 (~$258K)
• · COO Ye Gang sold 10,104 Class A ordinary shares at $113.15 (~$1.14M)
• · COO Ye Gang sold 7,596 Class A ordinary shares at $113.93 (~$865K)

04-09-2026

Falcon's Beyond Global, Inc. announced the timing and details of its regular quarterly dividend on its 11% Series B Cumulative Convertible Preferred Stock. The dividend will be paid in the form of PIK (payment-in-kind) shares at a rate of $0.137123 per share, or approximately 0.027 shares per existing share, with cash in lieu of fractional shares. The record date is September 16, 2026, and the payment date is October 1, 2026.

• · Dividend is paid in PIK shares (not cash) until January 1, 2027, unless certain cash payment conditions are met.
• · Cash in lieu of fractional shares is paid at $0.137123 per share multiplied by the fractional share.